share_log

HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $11 Price Target

Benzinga ·  Mar 18 10:49

HC Wainwright & Co. analyst Emily Bodnar reiterates Sana Biotechnology (NASDAQ:SANA) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 255

Recommended

Write a comment